Clinical trial
Aspirin and Enalapril in Microalbuminuric Type 2 Diabetes Mellitus Patients
NCT00427271 · Hospital de Clinicas de Porto Alegre, Other · Unknown status
Key facts
| NCT number | NCT00427271 |
|---|---|
| Title | Aspirin and Enalapril in Microalbuminuric Type 2 Diabetes Mellitus Patients |
| Official title | Aspirin and the Antiproteinuric Effect of Enalapril in Microalbuminuric Type 2 Diabetes Mellitus Patients: a Randomized, Double-Blind, Placebo-Controlled Study |
| Lead sponsor | Hospital de Clinicas de Porto Alegre, Other |
| Status | Unknown status |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Diabetes Mellitus, Microalbuminuria |
| Intervention type | Drug |
| Interventions | aspirin |
| Enrollment | 20 |
| Start date | Mar 1, 2003 |
| Completion | Jan 1, 2007 |
| First posted | Jan 29, 2007 |
| Last update posted | Jan 29, 2007 |
| Countries | Brazil |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: